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It is well known from clinical experience
that there are certain differences in the in-
cidence of development of immunological re-
actions in various groups of people. Some
individuals become strongly sensitive when ex-
posed to even a very little amount of weak
sensitizer for a very short time. However,
others fail to become sensitized after exposure
to a far higher concentration of a strong
sensitizer for a relatively long time.
The explanation for this fact can be sought
in differences in genetic influences. As early as
1650 Sennertus described the familial incidence
of asthma.
The aim of this paper is to review our
knowledge of the genetic control of immunologi-
cal phenomena in both experimental animals nnd
in human subjects. The first part will take
the fonn of a survey of the genetic factors
involved in delayed hypersensitivity reactions
in experimental animals and of the occurrence
of diseases based on immunological phenomena.
The second part will deal similarly with
humoral antibody formation and the final part
with the incidence of diseases associated with
auto-immune phenomena.
I. CELL-ManrAran IMMUNE REACTIONS
There has not been very much work on
the problem of the genetic control of delayed
hypersensitivity reactions. However, the small
amount of work that has been done in this
field has been more intensive and concentrated
than the work in other fields with the result
that mbre precise conclusions can be drawn
about the factors and mechanisms involved.
A. In Experimental Animals
The earliest approach to the problem was by
Landsteincr and Jacobs (1935) and Landsteiner
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and Chase (1937) who worked with simple
chemical compounds and noticed that identical
treatment leads sometimes to different degrees
of hypersensitivity within the same group of
guinea pigs, even when kept under the same
living conditions (temperature, food etc.).
Landsteincr and Chase (1940) tried to breed
guinea pigs according to whether they had a
high or low susceptibility to experimental
sensitization and this work was further ex-
tended by Chase (1941). Chase (1941) was
able, after a very careful selection, to establish
two strains of guinea pigs which differed sig-
nificantly in their degree of sensitivity, despite
the same sensitizing procedure and the same
environmental conditions. One group gave, in
almost all animals, uniform intense reactions
after only a brief course of sensitization by
intradermal injections with a total of 0.01 mg
dinitrochlorobenzenc (DNCB) while the other
group responded with only a low grade sensi-
tivity to an even longer course. However, these
animals were not complete non-responders and
the reactions seen were far from uniform. Some-
times some of the offspring of poor reactors
exhibited stronger reactions than either parents.
Chase also observed differences in guinea pig
strains procured from different breeders.
Breeding experiments with parents, selected
for their reactivity to poison ivy, showed again
that the degree of susceptibility was hereditary
and that groups of good and poor responders
can be established. There was a rough ac-
cordance between the sensitivities developed to
DNCB and poison ivy, but sometimes there was
a discrepancy in that a good responder to
DNCB would be a poor responder to poison
ivy and vice versa. This fact could be ex-
plained by different genes, which control the
ability of the animals to be sensitized to these
different substances. These experiments show
very clear proof that there is genetic control
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in the manifestation of hypersensitivity to
simple chemical oompounds.
After this basio work there was a gap of
more than twenty years before the problem of
genetic control in delayed hypersensitivity was
taokled again. Stone (1962) sensitized Hartley,
strain 2 and strain 13 guinea pigs to M. tu-
berculosis and determined the minimal dose
necessary for inducing a state of hypersensi-
tivity. In these experiments he found that
Hartley guinea pigs were more easily sensitized
than the inbred strains 2 and 13 and strain
13 more than strain 2. More recently research
into genetic differences in the immune response
has turned to the usc of synthetic polypeptides.
These arc simple chemically defined antigens
and it is therefore easier to follow more closely
the genetic control of the sensitization process.
Kantor, Ojeda and Benaccrraf (1963) ob-
served that it was possible to immunize only
40% of Hartley strain guinea pigs to the
dinitrophenyl (DNP) group linked to poly-
lysinc and they assumed that this reflected
constitutional differences, presumably genetic,
among these randomly bred guinea pigs. Only
those guinea pigs capable of reacting to one
antigen (DNP-Polylysinc) were able to react
to the DNP group linked to the immunologi-
cally unrelated copolymer of glutamine and
lysine. The constitutional difference was there-
fore thought to operate at a stage before the
formation or selection of the immunological
spcoificity. This difference in sensitizability
could be due to the presence or absence in
guinea pig macrophages of an enzyme capable
of splitting lysyl-peptide bonds. Levine, Ojeda
and Benaeerraf (1963a) extended this study by
using four different hapten poly-L-lysinc con-
jugates and found that individual random bred
Hartley guinea pigs were either capable of
developing an immune response either to all
of these compounds or else to none of them at
all. The ability to respond immunologically ap-
pears therefore to depend not on the structure
or the 'degree of forcigness' of the haptenie
group but on the ability to metabolise the
conjugate in a precise way. In a further study
Levine, Ojeda and Benacerraf (1963b) per-
formed breeding experiments and also used in-
bred strains of guinea pigs. They demonstrated
that 82% of 22 offspring of 8 pairs of responder
parents were responders, whereas none of the
26 offspring of 9 pairs of non-responders
could be sensitized. None of 11 strain 13 guinea
pigs and all of 40 strain 2 animals could be
sensitized to the hapten poly-L-lysine con-
jugates. This fact is in favour of the genetic
control being by a single Mendelian dominant
gene. Levine (1964a) also compared the
antigenicity of benzylpenioilloyl-poly-L-lysine(BIPO-PLL) conjugates in random bred and
inbred strain 2 guinea pigs. Although he did
not find any significant differences among these
strains, the results of these experiments sug-
gested that the first step of immunization
could be the metabolic breakdown of the anti-
gen. This could then be followed by the
coupling of antigenic fragments with RNA,
which could require an activating enzyme
specific for the lysinc side chain. Difference in
the presence of that enzyme, which may be
hereditary, could explain differences in im-
munizability of the different strains. Further it
was found (Levine, 1964b) that certain BPO-
polylysines were not antigenio in any of the
strains used. Levine and Benacerraf (1964)
started with the suggestion that the difference
between responder and nonresponder guinea
pigs may reside in their abihties to metabolise
the poly-L-lysine carrier properly. This might
be due to a presence of a single essential
metabolic enzyme, which was either responsible
for degradation of the PLL carrier or in-
volved in the metabolic process. This in turn
could lead to the formation of the specific
inducer, bearing the antigenic dominant. They
also suggested that in addition to the known
requirements for antigenicity (presence of anti-
genie determinants and ability to be degraded
by retioulo-endothelial tissues), the resulting
degradation products must undergo specific
metabolic steps to induce an immune response.
However, these steps have not yet been
identified. Nevertheless, it was discovered that
the enzymatic digestion of the PLL molecule
is not impaired in unresponsive guinea pigs.
It was also found (Vassalli, Levine and
Benaeerraf, unpublished observation) that the
uptake of antigen by lymph node maorophagos
in unresponsive guinea pigs was also unim-
paired.
In a further set of experiments Levine and
Benacerraf (1965) crossed random bred Hart-
ley guinea pigs, which do not respond to
hapten-PLL conjugates, with heterologous re-
sponder guinea pigs and found that the off-
GENETIC BACKGROUND OF CERTAIN IMMUNOLOGICAL PHENOMENA 221
spring included at least one nonresponder. Of
31 offspring from 10 pairs of psrents con-
sisting of nonresponders and heterologous re-
sponders, 14 were responders. This result
supports the view that nnmune response to
PILL conjugates is a genetically transmitted
autosomal Mendelian dominant controlled by
one single gene. A very broad analysis of the
genetic control of immune responses was made
by Green, Paul and Benaeerraf (1966). They
suggested two main objections against the by-
pothesis that the ability to produce immune
responses to hapten PLL conjugates in good
responders depends on the ability to metabolise
the PLL carrier. Firstly, there are no dif-
ferences between responders and non-re-
sponders in the enzymatic digestion of the
PLL molecule concerned, and secondly, the up-
take of the molecule by lymph node macro-
phages was not altered in unresponsive guinea
pigs. Therefore they suggested that the gene
governing antigenicity controls a specific meta-
bolic step prior to the recognition of specificity,
which involves the formation of an unidentified
inducer of immunogenicity. The alternative
possibility is that the gene controls the recogni-
tion of the PLL specificity as an antigen. In
very carefully performed experiments the au-
thors found that DNP poly-L-lysine which
behaved as a complete antigen in responder
guinea pigs can behave in nonresponders as a
hapten. Guinea pigs genetically unable to rec-
ognise the antigenicity of DNP poly-L-lysine
respond to immunization with the conjugates of
DNP poly-L-lysine to several different al-
bumins. However, they produced humoral
antibodies to the DNP group only and did not
show delayed hypersensitivity to DNP-PLL.
The conjugates of DNP poly-D-lysine to
albumin did not appear to be antigenic at all.
As the result of these experiments two hy-
potheses of genetic control were discussed:
(1) the 'metabolic gene hypothesis' which as-
sumes a metabolic reaction in the poly-L-lysine
prior to recognition of specificity, possibly in
the macrophages, and results in the formation
of a specific inducer of immunogenicity; (2)
the 'specific gene hypothesis' which supposes a
specific immunological recognition of poly-L-
lysine as a partial antigen/antibody complex
capable of reacting with it, whereas there is no
gene capable of recognising poly-D-lysine. The
results of the experiments of Green et ol. (1966)
arc in favour of the 'specific gene hypothesis'.
In continuation of these experiments Green,
Vassalli and Benaccrraf (1967) discovered that
animals which were genetically nonresponders
when immunized against DPN-poly-L-lysine
complexed with a foreign albumin, produce two
types of antibodies one against the DNP-poly-
L-lysine hapten and another against antigenic
determinants of the conveyor molecule. Each
type is produced in separate plasma cells.
Schlossman, Yaron, Ben-Efraim and Sober
(1965) extended the knowledge of the genetic
differences in Hartley, strain 2 and strain 13
guinea pigs on immunization with the series of
a,N-DNP-L-lysines. It was possible to sensitize
the majority of Hartley guinea pigs to DNP-
poly-lysines consisting of seven or more lysine
molecules and all strain 2 animals to poly-
peptides consisting of nine or more L-lysine
residues but only 66% of animals to DNP
linked to eight lysinc residues. IDNP linked to
shorter chain peptides of L-lysine were not
antigenic. DNP-poly-D-lysines were not anti-
genie at all. An attempt to sensitize strain 13
to any of the copolymers of L-lysine failed
completely.
Bcn-Efraim, Arnon and Sela (1966) in-
vestigated the antigenicity of conjugates of
polylysinc with peptide chains of tyrosine and
glutamic acid or DNP-groups. These were im-
munogenic in strain 2 guinea pigs but were not
able to sensitize strain 13 animals. The same
was found to apply to other lysine-containing
copolymcrs, whether linear or multichain. Co-
polymers devoid of lysine were immunogenic in
both strains. It was suggested that strain 13
guinea pigs were unreactive to polylysinc and
the sole presence of sequences of lysinc in other-
wise antigenie copolymers make them non-
immunogenic for that strain. This was con-
firmed in experiments using polylysinc linked
to rabbit serum albumin as antigen where the
lysine pcptidc chain serves as a haptcn which
was also non-immunogenic in strain 13. This
failure of the immune response was thought to
be due to clusters of positive charges within
the molecule. However, it could have been due
to some other, as yet, undefined properties of
the molecule or of the animal.
Bcn-Efraim and Maurer (1966) attempted to
sensitize Hartley, strain 2 and strain 13 guinea
pigs and their F1 hybrids with a series of
222 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
random copolymers of amino acids and ag-
gregates of polymers with methylated plasma
albumin. The results obtained in these guinea
pig strains and mainly the ability of all F1 hy-
brids to be sensitized support the hypothesis
that the ability to respond immunogenieally is
genetically controlled and is a dominant
Mendelian trait. Oligolysine containing copoly-
mers, glutamie acid-alanine and glutamie acid
methylated guinea pig plasma albumin ag-
gregates are immunogenic for strain 2 guinea
pigs only and the eopolymers glutamie acid-
alanine tyrosine and glutamie aeid-tyrosine +
methylated bovine plasma albumin aggregate
were immunogenic in both strains. There were
differences in the ability of some strains to show
the delayed hypersensitivity reactions and pas-
sive cutaneous anaphylaxis (PCA) to different
antigens.
Ben-Efraim, Fuchs and Sela (1967) con-
tinued these studies and found that some anti-
gens such as linear eopolymers of tyrosine,
glutamic acid and alanine are immunogenic in
both strains 2 and strain 13. Linear and
branched eopolymers containing lysine are im-
munogenic in strain 2 only and linear copoly-
mers of tyrosine and glutamie acid are only
immunogenic in strain 13. The D-optieal iso-
mers were not immunogenic in either strain.
The immunogenic responses in F1 hybrids of
the two strains were identical with that of
strain 2, suggesting that the genetic de-
terminants of strain 2 are dominant. Polflk,
Barnes and Turk (1968) studied the genetic
control of three different inorganic metal
sensitizers, potassium dichromate, beryllium
fluoride and mercuric chloride, using Hartley,
strain 2 and strain 13 guinea pigs. It was
found that only a proportion of outbred
Hartley strain guinea pigs could be sensitized
with these agents, but unlike the findings of
Chase (1941), there was no parallelism in the
reactivity of guinea pigs to diehromate and
beryllium. Strain 2 guinea pigs could be sensi-
tized to diehromate and beryllium but not to
mercury and strain 13 could be sensitized to
mercury but not to the other metals. Cross-
breeding experiments using sensitivity to beryl-
lium fluoride as a marker in Hartley guinea pigs
indicated that the ability to react to a particu-
lar metal is inherited as a simple Mendelian
dominant trait. Further it would appear that
this ability to react to different metals is
controlled by different genes. The explanation
of the differences of the ability of strain 2
and 13 to be sensitized to different metal com-
pounds is yet not clear and could be similar
to that of the synthetic antigens mentioned
above.
Despite the fact that the precise mechanism
of the genetic control of delayed hypersensitiv-
ity cannot yet be explained, the evidence
indicates very strongly that the process of sensi-
tization is genetically controlled.
B. In the Human
Despite the fact that the genetic control of
delayed hypersensitivity reaction in experi-
mental animals appears now to be beyond any
doubt, very little has been done to demonstrate
and analyse the genetic factors and their role in
human diseases based on delayed hypersensitiv-
ity reactions. This is even more surprising,
when one considers that contact eczema, one
of the main skin diseases due to delayed hy-
persensitivity, has been investigated from a
number of other different approaches, as it is a
frequent cause of industrial morbidity. Biber-
stein (1927) described a case of polyvalent
sensitization against different house plants in a
mother and her two daughters.
Wedroff and Dolgoff (1935) sensitized 72
patients with eezematous dermatitis and 20
control patients to DNCB. They then tested
them with different concentrations of the anti-
gen. In 50 of the patients with eczema the
reactions were greater and the degree of
sensitivity higher than in controls. This is in
favour of the assumption that there is a disposi-
tion to become sensitized in a certain but not
clearly defined group of people.
Sulzberger and Baer (1938) were able to
sensitize five subjects to 1—2—4 trinitrobenzene
but only one of this group to 1—3—5 trinitro-
benzene. This again suggests the presence of a
constitutional factor, which could play a certain
role in sensitization at least to weak sensitizers.
Landsteiner, Rostenberg and Sulzberger (1939)
extended the studies in individual differences in
the ability to become sensitized and tried to
sensitize a group of 82 persons to both DNCB
and paranitroso-dimethylaniline (PNDMA).
They were able to divide their subjects into
three groups: (1) sensitized to DNCB only,
(2) sensitized to PNDMA only, and (3) sensi-
tized to both DNCB and PNDMA. Altogether
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SO subjects could be sensitized to both or one of
these agents, and 32 subjects could not be
sensitized to either. Of the 50 responders 21
reacted to both compounds, 20 to DNCB only
and 9 to PNDMA only. DNCB sensitized
50% and PNDMA 36.6% of the persons
tested. From the results it is easy to understand
why patients affected with recent or active
contact dermatitis are more susceptible to
sensitization with other simple chemical sub-
stances, as has been shown by Sulzberger and
Rostenberg (1939). Schwartz (1940) observed a
lower frequency of occupational eczema in ne-
groes than in white people and in people with
dark hair than in those with blonde hair.
Hofbauer (1943) tried to describe more pre-
cisely the characteristics of people who are more
frequently affected by contact eczema. His
description was based on a detailed study of
120 patients with occupational eczema of di-
verse origin, and of 105 patients with other skin
diseases. As a result of this study Hofbauer was
of the opinion that the group predisposed to
contact dermatitis showed a predominance of
blood group A, were mostly leptosomic in body
type, vagotonic, with blonde hair and light skin
and had an allergic family history. Despite the
fact that this study is based on an analysis of
two groups of 120 and 105 patients only, it is
of great interest that a positive allergic family
history was found in 43% of patients with
eczema and only in 23% of patients with other
skin diseases.
In the introduction to his book on contact
dermatitis, Waldbott (1953) described a study
of the frequency of this disease in different
areas and found that negroes are affected less
often than whites. He did not find differences
between North American Indians and whites in
hypersensitivity to poison ivy but he found that
eskimos did not develop sensitivity to poison
ivy at all. He also mentioned that allergic pa-
tients are more likely to come from allergic
families. Hanhart (1953) expressed the same
opinion. Niermann (1964) described a pair of
twins, who both worked on a farm and both
suffered from contact eczema of the hands af-
ter contact with milk fat. This was the only
positive pair out of 19 twins which he observed
with contact eczema. In all the others the
eczema occurred in one of the twins only.
Recently Forsheck, Skog and Ytterborn
(1966) tested siblings and children of patients
with contact dermatitis to common routine
allergens and were able to demonstrate that
these persons arc more often positive than the
controls. They also found a higher frequency of
atopic diseases among the families of patients
with contact sensitivity. Walker, Smith and
Maibach (1967) studied the genetic factors in
human allergic contact dermatitis. They found
that children whose parents had been sensitized
to nitrosodimethylaniline (NDMA) became
sensitized at a higher rate than children of
non-sensitized parents. Evidence regarding the
genetic factors in drug eruptions is contro-
versial, both Albahary (1953) and Lindemayr
(1959) did not consider that genetic factors
have any influence in drug eruptions. Riehl
(1927) however, described the familial occur-
rence of Salvarsan dermatitis in a father and in
his two children, treated for syphilis. Gruetz
(1930) also reported a case of Salvarsan al-
lergy in a mother and her daughter. Blumen-
thal and Jaffy (1933) observed hypersensitivity
to both quinine and salvarsan in a mother and
her child. Kriegk (1951) described four cases
(mother and child; two sisters; three sisters;
and a father and daughter) where there was a
familial occurrence of Salvarsan dermatitis.
This would suggest that the genetic control
of Salvarsan dermatitis was similar to that
found in dermatitis due to other chemical
sensitizing agents. However, Niermann (1964)
did not find a concordant occurrence of drug
eruptions after the intake of analgesics, sul-
phonamides and iodine in seven pairs of twins.
Samter and Berryman (1958) have tried to
explain the genetic differences in disposition to
contact eczema and drug eruptions by genetic
differences in enzyme activity. People with
deficient enzyme activity would be unable to
neutralise some antigens and therefore become
more easily sensitized. This weakness could be
an inherited characteristic (Motulsky, 1957)
and related to the inherited enzymatic de-
ficiency of erythrocytes found in negroes
(Brown, 1958). This would be consistent with
the observations in experimental animals, men-
tioned above.
In conclusion it could be said that although
the genetic control of hypersensitivity to drugs
and contact allergy in man is not proved to
the same extent as it is in experimental ani-
mals, the observations which have been made
so far are consistent with this concept.
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II. HUMORAL ANTIBODY FORMATION
A great Dumber of skin diseases are based
on reactions of a range of antigens with dif-
ferent humoral antibodies and therefore it will
be useful to give a survey of the genetic con-
trol of humoral antibody production in experi-
mental animals.
A. In Experimental Animals
In 1928 Lewis and Loomis described a dif-
ference in haemolytic antibody production by
different inbred strains of guinea pigs. Using
guinea pigs of strain 2, 13, 32 and 35 they
found that animals of strains 35 and 13 pro-
duced much more antibody against bovine and
sheep red cells than those belonging to strain
2 and 32. Strain 35 proved to be a better
antibody produccr than strain 13. The authors
drew the conclusion that immunological re-
activity is nn inheritable characteristic.
Gorer (1936a, b) immunized rabbits with
erythrocytes of different mouse strains (black,
albino and agouti) and showed three different
antigenic factors in mouse erythrocytcs and a
characteristic distribution of these factors in
different strains. Antigen II was present in
albinos and absent in black mice and its
presence was determined by a single dominant
gene. In further experiments (1936 b) he
found that the pure line of black mice was
sharply divisible into two groups by direct
agglutination tests. Cross experiments con-
firmed that the presence of the antigen was
controlled by a single determinant gene.
Much later Davidsohn and Stern (1949 a) in
their studies on strains of mice with low and
high incidences of mammary tumours were
able to show that the natural anti-sheep red
cells agglutinins were present much more fre-
quently and in much higher titres in C57 black
inbred mouse strains with a low incidence of
mammary tumours than in C3H, DBA or
Marsh-albino strains with a high tumour in-
cidence. Similar differences, however, were not
found in the incidence of natural agglutinins
against human red cells. In a further experi-
ment (1949 b) differences were found in the
ability of these strains to produce immune
antibodies (agglutinins and haemolysins) against
sheep and human red cells. The highest levels
of immune antibodies were found in C57 black
mice and lower levels in C3H and DBA mice.
The Marsh-albino, Bagg-albino C and Akm
strains appeared to develop low titres only.
Experiments on the activity of the reticulo-
endothelial system, using the uptake of congo
red, showed that the C57 black strain was more
active and more responsive than the five other
strains. It was suggested that this ability was
probably controlled genetically. In further ex-
periments (Davidsohn and Stern, 1950 a, 1950
b, 1954; Stern and Davidsohn, 1954 and Stern,
Brown and Davidsohn, 1956) the same au-
thors found no correlation between the level of
natural anti-sheep antibodies and the presence
or absence of the milk agent associated with
the development of mammary tumours in
C3H, A, D2 and I inbred strains. They were,
however, able to demonstrate differences in the
presence of the Forssman antigen, which was
present in normal and neoplastic tissues of
C3H, DBA and CS7H black mouse strains,
but absent in Marsh-albino, Bagg-albino, Bagg-
albino C, Akm, C57 brown and I mice. In an
investigation of the natural agglutinins against
sheep and chicken red cells in 13 different in-
bred mouse strains (Davidsohn and Stern,
1954) considerable differences were found in the
incidence of the antibodies. However, there
was no correlation between the presence of the
anti-sheep and anti-chicken antibodies in in-
dividual strains. This indicates that the pro-
duction of anti-sheep antibodies is probably
controlled by a different genetic factor than
that controlling the production of anti-chicken
red cells antibodies. Further, each mouse strain
showed a characteristic pattern of distribution
of immune antibody titres. The immune re-
sponses were not related to the presence of
natural haemagglutinins and there was also no
correlation between the levels of immune anti-
bodies produced against sheep or chicken red
cells. Generally it was found that there was a
high response in strains with a low incidence of
tumours, and a low response in those with a
high incidence. It was concluded (1956) that
genetic differences in the ability to produce
natural agglutinins are controlled by one or
more genetic factors and that the factors as-
sociated with a low or absent level of circulat-
ing antibody are incompletely dominant.
Dineen (1964) studied the differences in im-
munological responses to sheep red cells be-
tween and within nine inbred strains of mice
and found that the differences in the titrcs of
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antibodies produced by different animals
witlim a single strain was only 2.7%. However,
the difference in titres in animals of different
strains averaged 12.9%. As a result it was as-
sumed that the genetic component was a major
source of immunological variation. Sobey and
Adams (1955) also investigated immunological
responses to sheep red cells in mice. They
studied the antibody responses of 228 parents
and 456 offspring of albino mice, but the re-
sults suffered a large sampling error because of
variation in response from generation to genera-
tion, the significance of which was not ap-
preciated at the time. Therefore a new approach
to this problem was sought by using female
mice of the same generation from lines with in-
creased or decreased reactivity to oestrogens
(Claringbold Sobey, and Adams, 1957). It
was found that the primary antibody re-
sponse to sheep red cells was genetically con-
trolled, but there was no evidence that the ge-
netic control of the secondary response was re-
lated to the control of the primary response. The
high oestrogen selection line gave a higher pri-
mary antibody response than the low one. How-
ever, this difference could only be detected if the
antigen was injected by the intraperitoneal
route. On the other hand there was a signifi-
cant difference between the two lines in their
secondary response irrespective of the route of
administration. The low oestrogen sensitivity
line gave a higher secondary response than the
high oestrogen sensitivity line. Thus there was
no correlation between the intensity of the
primary and secondary responses in the two
different strains, which shows that there must
be different factors governing the primary and
secondary antibody responses.
As far as antibodies to soluble antigens are
concerned, Fink and Quinn (1953) found
genetic variations in the production of circulat-
ing antibodies against egg albumin in five in-
bred mouse strains. Different results were ob-
tained according to the route of injection of
the antigen. Strains DBA and C57BL/6 were
the best responders to intramuscular injection
and strains BALE/C and C57BL/6 to intra-
peritoneal injection. They found no correlation
in the response to two different antigens, egg
albumin and pneumococcal polysaceharide. The
strains DBA/1, C3H and A/L appeared to
respond well to pneumococcal polysaecharide
but BALE/C and C57BL/6 responded poorly,
showing again as in previous reports that dif-
ferent genetic factors appeared to be involved
in the control of the antibody response.
Kleezkowska and Kleezkowski in 1939 were able
to divide families of rabbits into strong, medium
and weak responders according to their immuno-
logical reactivity to human serum. They
thought this finding was due to the segregation
of a single gene.
Sobey (1954) studied the inheritance of anti-
body response to tobacco mosaic virus in
rabbits and found that the ability to produce
antibodies to this virus is genetically con-
trolled and it was possible to breed strains
with high and low secondary response to this
antigen.
Differences were also shown (Sang and
Sobey, 1954) in the immune reactivity of rab-
bits of small Ermine Rex and Flemish Giant
strains, to various protein, bacterial or viral
antigens. However, they could not demonstrate
any genetic control in the response to bovine
plasma albumin.
Maurer (1964) immunized four inbred strains
of mice (C57BL, C3H, 129 and BALE/C) and
random bred animals with copolymers of glu-
tamie acid and lysine (GL40), glutamie acid
and alanine (G,A40) and glutamic acid, lysine
and alanine (GLA). All strains responded to
GLA but only C57BL to GL.
Pinchuk and Maurcr (1965) studied the
ability of seven different strains of mice to
form antibodies against a random copolymer of
glutamine, lysine and alanine (G57L38A6) and
found that this ability is controlled by a
dominant Mendelian factor. Three of the strains
which he investigated were 100% responders,
the others did not respond at all. However, all
seven strains could make antibodies to related
polymers which had a higher alanine content.
Breeding experiments using the progeny of
Swiss mice indicated that a similar genetic
factor was involved.
McDcvitt and Sela (1965, 1967), using
synthetic antigens in CBA and 057 mouse
strains, demonstrated that although both strains
responded equally to bovine serum albumin,
they showed tenfold or more differences in the
antigen binding capacity of their sera after im-
mimization with poly- (tyr, glu) -poly DL-ala-
nine-p olylysinc E[T, G) -A-L. Neither strain re-
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sponded to the polyglutamie acid determinants,
both strains responded to the poiy- (phenyl
alanine, glutamie acid) determinant. C57 re-
sponded well to two different antigens with
poly- (tyrosine, glutamie acid) determinants
and OBA to poly-(histidine, glutamie acid)
(H,G)-A-L determinants. In crossing experi-
ments, F1 hybrids showed a definite genetic
control of antibody response due to a single
major genetic factor with one or more
modifying factors. This control appeared to be
specific for the antigenie determinant. The
CBA strain responded to (H,G)-A-L and C57
to (T, G) -A-L. The genetic control of these
antigens is dominant and controlled by a num-
ber of different genes.
Arquilla and Finn (1963) using inbred
strains of guinea pigs and insulin as an antigen,
showed that strain 2 guinea pigs are able to
produce antibodies to some parts of the bovine
insulin molecule, to which strain 13 guinea pigs
do not respond. They also assumed that there
was a genetic control of antibody production
with respect to the determinant groups toward
which antibodies are directed.
Weiser, Golub and Hamre (1941) used di-
luted egg-white as antigen to show differences
in white, brown and black mouse strains in
the production of preeipitins and in the mani-
festation of anaphylaxis. It was found that
the white mouse strain was the best responder,
while the black one reacted very poorly. Similar
observations have been made with antigens of
bacterial and viral origin. MeMaster and
Hudack (1934) were also able to demonstrate
differences in agglutinin titres in a susceptible
and a resistant strain of mice immunised with
killed cultures of S. pczratyphi B, B. buteridis
and B. prodigiosus.
Prigge (1937) studied the range of doses of
diphtheria toxoid necessary to protect guinea
pigs of various inbred and random bred strains.
He found that in one of his inbred strains he
needed from 1 to 25 times a standard dose of
toxoid to get protection. However, in outbred
animals the range of dose necessary to get
protection varied from one standard dose of
toxoid to 32,000 standard doses. Gorer and
Sohutze (1938) compared antibody production
against H and 0 antigens of S. typhi murium
and S. enteridis with the development of re-
sistance to these bacteria in a number of mouse
strains. Two inbred strains and two outbred
strains seloetod for resistance and susceptibility
were studied and differences were found in these
four strains. Seheibel (1943) bred two strains
of guinea pigs one of which was composed
mainly of good producers of diphtheria anti-
toxin, whereas the members of the other
strain were poor producers. After six genera-
tions the good strain contained 97.5% good
producers of antitoxin and the other had
only 11.5% of animals which were good pro-
ducers. Hereditary influences in the antibody re-
sponse to diphtheria vaccine in guinea pigs
are also described by HoIt (1951).
Ipsen (1954) working with tetanus toxoid
found that various inbred strains of mice dif-
fered in that some strains needed ten to
thirty times more antigen than others to
produce primary immunity to toxin injected in
the unimmunized state. These strains, however,
did not differ in their susceptibility to a lethal
dose. He found (1959) that differences between
individuals of the same strain existed and these
differences were not found to be greater in
outbred than in inbred strains. The possible
explanation of these differences was thought to
be due to a variation in the ease and speed
with which cells first mature into specific
antibody producing cells. However, the rate of
multiplication of these cells was not considered
to bear a relation to the immunizability of the
animals. Sang and Sobey (1954) in their ex-
periments with two rabbit strains (small Ermine
Rex and Flemish Giant) and their crossed off-
spring found that the secondary antibody
response to tobacco mosaic virus was genetically
controlled and there was a correlation with the
genetic control of antibody production to diph-
theria toxoid.
In more recent work Sobey and Adams
(1961) studied the antibody response to Vi
and 0 antigens, to Rhisobium meliloti and to
two strains of influenza virus (MEL and LEE)
in mice. They drew the conclusion that one
could only detect the genetic control of the
immune response to substances containing one
antigen only. If more than one antigen was
present the genetic control of the production of
antibodies against these antigens could be in-
dependent and it would be difficult to demon-
strate genetic control of the immune response
to the substance as a whole.
GENETIC BACKGROUND OF CERTAIN IMMUNOLOGICAL PHENOMENA 227
All the papers reviewed give strong evidence
that the formation of humoral antibodies to
different antigens in varions species of labora-
tory animals is to some extent controlled
genetically. The importance of genetic factors
has also been shown in the human, where the
emphasis is on studies in famihes and especially
in twins.
B. In the Human
There is a considerable amount of data
about the genetic control of the production of
different types of antibodies in experimental
animals, although a deep analysis of how that
genetic control really works is still missing. It
is not known, however, at what stage and by
what means hereditary mechanisms control
antibody production. In humans we are con-
fined to studies of the familial occurrence of
different allergic conditions and diseases, and of
their occurrence in twins. The only experi-
mental work on hereditary factors in humoral
antibody production in humans is that of
Carlinfanti (1948). He investigated the anti-
A1, Anti-A2 and Anti-B hemagglutinin titres in
51 families with 159 children and he found that
there was a high degree of correlation between
the titres found in parents and in their children.
III. AUTO-IMMUNE PHENOMENA
Auto-immune phenomena have recently been
shown to be associated with many diseases both
in general medicine and in dermatology. Despite
the large amount of work that has been done
in this field, very little is known about the
genetic control of these phenomena. A good
survey of the present stage of our knowledge of
the genetic factors involved in the manifestation
of auth-immune phenomena in experimental
animals and in clinical medicine is in the report
of a Symposium on Auto-Immunity and Genet-
ics, held in Glasgow in 1966 (Olin. exp. Im-
munol. 3: suppl., 1967).
This paper will give only a brief review of the
experimental background of sonic auto-immune
diseases in certain inbred strains of laboratory
animals. This will be followed by a discussion
of the possible role of genetic factors in the
development of some skin diseases, which are
associated with auto-immune phenomena. This
will be based on studies which have been made
of the familial distribution of these diseases
and of their occasional occurrence in twins.
A. In Experimental Animals
Some of the earlier reports of the role of
genetic factors in auto-immune disease were
made by Olitsky, Casals and Tal (1950) and
Olitsky and Lee (1953). The authors sensitized
different inbred strains of mice with mouse
brain tissue homogenised in Freund's complete
adjuvant to produce allergic experimental en-
cephalomyelitis. They found that this disease
appeared more frequently in one strain, BSYS
mice, than in other strains.
Lipton and Freund (1953) who worked with
guinea pigs, immunized different inbred guinea
pig strains and outbred Hartley guinea
pigs with central nervous system tissue in
Freund's complete adjuvant in different doses
to find out the minimal dose sufficient to pro-
duce allergic encephalomyelitis. They found
that the dose of mycobacteria necessary for the
production of this disease in Hartley guinea
pigs was much less than that needed for the
other strains. These results were confirmed
nine years later by Stone (1962) who showed
that Hartley strain guinea pigs are more
susceptible to experimental allergic encephalo-
myelitis than inbred strain 13 guinea pigs, which
in turn are more susceptible than strain 2.
SImilar results were reported by McMaster,
Lerner and Mueller (1965) in experimental
allergic thyroiditis. They immunized Hartley
and strain 13 guinea pigs with thyroid ex-
tracts and estimated the frequency with which
allergic thyroiditis developed. The outbred
Hartley guinea pigs developed thyroiditis more
frequently than strain 13 animals, showing that
the Hartley strain is generally more sus-
ceptible to auto-immune disease than other
strains of guinea pigs. A possible explana-
tion of the differences in response of the dif-
ferent strains is that there might be some
genetic differences in their ability to process
the auto-antigens.
There are no reports of the genetic control of
auto-immune skin diseases in animals. An ex-
perimental model for auto-immune phenomena
in the skin is much needed at the present time.
In a recent report Holborow and Denman
(1967) summarised the spontaneous auto-
immune character of NBZ mice based on their
own studies, (Holborow, Barnes and Tuifrey,
1965), and those of Bielchowsky, Helyer and
Howie (1959), Burnet and Holmes (1963.
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1965), Bielebowsky and Bielchowsky (1964)
and Howie and Helyer (1965). They drew the
conclusion that the development of auto-im-
mune phenomena in this strain is an inherited
characteristic and is expressed in the heterozy-
gote, and that more than a single gene must
be involved in their manifestation. The auto-
immune abnormalities in NZB mice appears
thus to be an expression of their genetic consti-
tution.
B. In the Human
Lupus erythematosus, pemphigus vulgaris
and pemphigoid have been shown to be
associated with the presence of auto-antibodies
in the serum. The relation between discoid lupus
erythematosus and systemic lupus erythemato-
sus is by no means understood. The fact that
transition from discoid lupus erythematosus to
systemic lupus erythematosus occurs in only
1% of cases and that the sex ratio of female to
male patients differs in the two conditions
suggests they may have a different aetiology.
Because the genetic predisposition to the two
diseases is different the genetics of discoid
lupus erythematosus (DLB) should be con-
sidered separately. Observations in this as in
other skin diseases, are confined to studies of
the familial appearance and particularly of the
appearance of this disease in twins.
Interest in the familial occurrence of DLB
started as early as 1900 when Roth described
a ease of LB in two sisters and in the child
of one of them, and Rona (1901) reported
three sisters, two of whom had obvious DLB
and the third had a condition which was con-
sistent with, but not typical of DLB. Cohn
(1907) published a case of LB in siblings
(brother and sister), Sequcira and Balean
(1902) in two sisters, Brocq and L'Aubry (1900)
in mother and daughter, and Leredde and Pau-
trier (1902) in two brothers, but Jadassohn
(1904) considered these last three cases were
not typical. In later studies Truffi (1924) pre-
sented three sisters with this illness, Sidlick
(1929) two sisters, Michelson (1929) a brother
and sister, Veicl (1930) two sisters, a father and
daughter, Pautrier and Zorn (1931) two
brothers, Greenhouse (1932) and Abramowitz
(1932) a brother and sister, Willbrand (1932),
Grandy (1933) and Beek (1934) all described
DLB appearing in two brothers.
Mashkillcison and Ncradow (1936) de-
scribed eight families in which there was a
familial occurrence of LB in 17 patients. These
cases formed 12—15% of all cases of LB seen
at the Leprosarium in Moscow at that time.
They expressed the opinion that there is a
hereditary predisposition to LB. In the same
report mention was made of the first descrip-
tion of the familial occurrence of LB in a
brother and sister by Hutchinson in 1891.
Hirschberger (1936) found five cases of LB
in one family, two sisters, their aunt and two
daughters of one of the sisters. He considered
that DLB was associated with a constitutionally
conditioned, heritable reactivity of the skin.
Rabeau and Tlkrainczyk (1939) described a
case of LB in mother and daughter. Lot
(1951) described four cases of familial ap-
pearance in brother and sister, two brothers,
father, daughter and her two sons and in a
pair of monozygous twins, and Hopkins in
1952 described the disease in a mother, daughter
and a cousin of the mother.
Grflnhagen (1952) summarised that up to
that time the known cases of familial LB in-
cluded 21 pairs of siblings, three cases of three
brothers and sisters, three cases of fathers and
daughters and two cases of mothers and
daughters, one case consisted of father, daugh-
ter and two sons and another of two sisters,
their mother, her sister and a sister of the
father. The author also assumed that an im-
portant role in this disease was played by a
hereditary constitutional factor.
Further cases of the familial appearance of
LB have been reported by many other authors
including Bondet (1952), Burckhardt (1953),
Gate (1953), Marchionini (1953), Dunipe
(1956) and others.
Burckhardt noted that 6% of his cases of LB
had a familial distribution supporting the
opinion that heritable constitutional factors
were involved in the disease, but Nagy and
Daroczy (1962) found only one case of the
familial occurrence of LB in a series of 150
cases of LB seen in the Dermatology Clinic
in Debrecen.
The concordant appearance of DLB in twins
gives further support for the importance of
genetic factors in the development of this
disease. Reports of this type have been made
by Lot (1951), Grünhagen (1952), Davis and
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Gutridge (1951), Steagall, Ash and Fentznes
(1962), and Blumenf old, Kaplan, Mills and
Clark (1963). However, in none of these cases
did the disease develop at the same site, time
and form. There are also reports of the dis-
cordant occurrence of the disease (Niermann,
1964). Niermann (1966) discussed the data on
the familial occurrence of LIE in altogether 71
eases of which 41 were eases of chronic discoid
LE, 25 of acute DLE and 5 had both acute
and chronic forms of the disease. He rejected
five other eases, where the diagnosis was based
on the finding of LIE cells only without skin
or other organ lesions and concluded that
despite the great number of familial eases and
only a few cases of twins, the question of an
inherited genetic factor in this disease was
still open. Rowell (1967) is of the opinion that
in DLE the disease is controlled by a sex-
linked dominant gene localised on the X cliro-
mosome.
Observations on the familial occurrence of
the two other skin diseases associated with
auto-immune phenomena are much more scanty.
Feldmann (1936) reported a case of pemphi-
gus vulgaris in two brothers, Greenbaum
(1940) in father and son and in two sisters.
Miller and Frank (1949) in a man and his
two sisters, Maragnani (1959) in three mem-
bers of one family. Pierini (1956) in siblings,
and Bukharovich (1959) in a mother and her
daughter. The only report of a case of twins
with the concordant occurrence of pemphigus
vulgaris was made by Corriciati (1935). Nier-
mann (1966) in a review of his observations
could not find enough support to decide
whether there was any genetic control of this
disease.
There is no report of the familial occurrence
of Behcet's syndrome, and other diseases as-
sociated with auto-immune phenomena.
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